Clinical trialNCT02813694CompletedPhase 3Interventional

Study to Compare Lefamulin to Moxifloxacin for the Treatment of Adults With Pneumonia

SponsorNabriva Therapeutics AGEnrollment738Community Acquired Pneumonia

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This study evaluates the safety and efficacy of lefamulin, a pleuromutilin, for the treatment of adults with moderate community-acquired bacterial pneumonia

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Leanne Gasink, MD
Nabriva Therapeutics AG
Study Chair
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

155 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Argentina

Site 3056
Buenos Aires, Argentina
Site 3059
Buenos Aires AV, Argentina
Site 3052
Córdoba, Argentina
Site 3054
Córdoba, Argentina
Site 3057
Córdoba, Argentina
Site 3058
General Pacheco, Argentina
Site 3051
La Plata, Argentina
Site 3053
La Plata, Argentina

Brazil

Site 3154
Belo Horizonte, Brazil
Site 3153
Passo Fundo, Brazil
Site 3152
São José do Rio Preto, Brazil

Bulgaria

4162
Rousse, Bulgaria
Site 4154
Sliven, Bulgaria
4163
Sofia, Bulgaria
4164
Sofia, Bulgaria
4165
Sofia, Bulgaria
Site 4153
Sofia, Bulgaria
Site 4156
Sofia, Bulgaria
Site 4157
Sofia, Bulgaria
Site 4160
Sofia, Bulgaria
Site 4161
Sofia, Bulgaria
Site 4158
Stara Zagora, Bulgaria
Site 4159
Vidin, Bulgaria
Site 4152
Vratsa, Bulgaria

Chile

Site 3353
Santiago, Chile
Site 3356
Santiago, Chile
Site 3357
Santiago, Chile
Site 3354
Talca, Chile
Site 3352
Temuco, Chile
Site 3355
Valdivia, Chile

Georgia

Site 4256
Batumi, Georgia
Site 4252
Tbilisi, Georgia
Site 4253
Tbilisi, Georgia
Site 4254
Tbilisi, Georgia
Site 4255
Tbilisi, Georgia

Hungary

Site 4353
Budapest, Hungary
Site 4354
Budapest, Hungary
Site 4352
Mátraháza, Hungary
Site 4351
Törökbálint, Hungary

Latvia

Site 4451
Liepāja, Latvia

115 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Moxifloxacin →Lefamulin

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 31 Aug 2016
Primary completion: 31 Jan 2018
Completion: 31 Jan 2018
Last update posted: 23 Oct 2019
Registered enrollment: 738
Registry id: NCT02813694

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.